M&A Deal Summary

Invo Bioscience Acquires Wisconsin Fertility Institute

On March 20, 2023, Invo Bioscience acquired healthcare services company Wisconsin Fertility Institute for 10M USD

Acquisition Highlights
  • This is Invo Bioscience’s 1st transaction in the Healthcare Services sector.
  • This is Invo Bioscience’s largest (disclosed) transaction.
  • This is Invo Bioscience’s 1st transaction in the United States.
  • This is Invo Bioscience’s 1st transaction in Wisconsin.

M&A Deal Summary
Date 2023-03-20
Target Wisconsin Fertility Institute
Sector Healthcare Services
Buyer(s) Invo Bioscience
Deal Type Add-on Acquisition
Deal Value 10M USD

Target

Wisconsin Fertility Institute

Middleton, Wisconsin, United States
Wisconsin Fertility Institute provides care based on the latest medical evidence for a wide range of conditions, including all aspects of infertility, women's hormonal problems, abnormal female structural anatomy, and complex gynecologic surgery. Its services include both traditional medical interventions as well as complementary and alternative medical approaches: hormone treatments, fertility surgery, artificial insemination, in-vitro fertilization, donor sperm and oocytes, surrogacy and gestational carriers, and semen and ovarian tissue cryopreservation. Wisconsin Fertility Institute is based in Middleton, Wisconsin.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Invo Bioscience

Sarasota, Florida, United States
Category Company
Founded 2007
Sector Life Science
Employees25
Revenue 3M USD (2023)
DESCRIPTION

Invo Bioscience is a commercial-stage fertility company dedicated to expanding the assisted reproductive technology (“ART”) marketplace by making fertility care accessible and inclusive to people around the world. The company's primary mission is to implement new medical technologies aimed at increasing the availability of affordable, high-quality, patient-centered fertility care. Its flagship product is INVOcell, a revolutionary medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. Invo Bioscience was founded in 2007 and is based in Sarasota, Florida.

DEAL STATS #
Overall 1 of 2
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Wisconsin) 1 of 1
Country (United States) 1 of 2
Year (2023) 1 of 2
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-10-23 NAYA Biosciences

Aventura, Florida, United States

NAYA Biosciences is a group of companies dedicated to increasing patient access to life-transforming treatments in oncology, fertility, and regenerative medicine. NAYA’s capabilities in biology, cell and gene therapy, and artificial intelligence (AI) provide a synergistic platform for the accelerated clinical development and commercialization of these breakthrough treatments. NAYA Biosciences is based in Aventura, Florida.

Buy -
Mergr

Product

Company

Legal